Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use

British Journal of Haematology

Volumn 97, Issue 4, 1997, Pages 775-784

  Lowe, G D O ^a   Rumley, A ^a   Woodward, M ^b   Morrison, C E ^a   Philippou, H ^c   Lane, D A ^c   Tunstall Pedoe, H ^d  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cardiovascular disease; Coagulation factors; Coagulation inhibitors; Thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING INHIBITOR; FIBRINOGEN; PROTEIN C; PROTEIN S;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; THROMBOSIS;

EID: 0030860570     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1222936.x     Document Type: Article

References (58)

1. Allaart, C.F. & Briet, E. (1994) Familial venous thrombophilia. Haemostasis and Thrombosis. 3rd edn (ed. by A. L. Bloom, C. D. Forbes, D. P. Thomas and E. G. D. Tuddenham), pp. 1349-1360. Churchill Livingstone, Edinburgh.
2. Bailleisen, L., Bailey, J., Epping, P.-H., Schulte, H. & van de Loo, J. (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thrombosis and Haemostasis, 54, 475-479.
3. Bauer, K.A., Broekmans, A.W., Bertina, R.M., Conard, J., Horellou, M.H., Samama, M.M. & Rosenberg, R.D. (1988) Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood, 71, 1418-1426.
4. Bauer, K.A., Mannucci, P.M., Gringeri, A., Tradati, F., Barzegar, S., Kass, B.L., ten Cate, H., Kestin, A.S., Brettler, D.B. & Rosenberg, R.D. (1992) Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood, 79, 2039-2047.
5. Bauer, K.A. & Rosenberg, R.D. (1994) Activation markers of coagulation. Bailliere's Clinical Haematology, 7, 523-540.
6. Bauer, K.A., Weiss, L.M., Sparrow, D., Vokonas, P.S. & Rosenberg, R.D. (1987) Ageing-associated changes in indices of thrombin generation and protein C activation in humans: normative ageing study. Journal of Clinical Investigation, 80, 1527-1534.
7. Boerger, L.M., Morris, P.C., Thurnau, G.R., Esmon, C.T. & Comp, P.C. (1987) Oral contraceptives and gender affect protein S status. Blood, 69, 692-694.
8. Boisclair, M.D., Lane, D.A., Phillipou, H., Sheikh, M. & Hunt, B. (1993) Thrombin production, inactivation and expression during open-heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2. Thrombosis and Haemostasis, 70, 253-258.
9. Bovill, E.G., McDonagh, J., Triplett, D.A., Arkin, C.F., Brandt, J.T., Hayes, T.E., Kaczmarek, E., Long, T. & Rock, W.A. (1993) Performance characteristics of fibrinogen assays: results of the College of American Pathologists Proficiency Testing Program 1988-1991. Archives of Pathology and Laboratory Medicine, 117, 58-66.
10. Caine, Y.G., Bauer, K.A. & Barzegar, S. (1992) Coagulation activation following estrogen administration to postmenopausal women. Thrombosis and Haemostasis, 68, 392-395.
11. Ceriello, A., Pirisi, M., Giacomello, R., Stel, G., Falleti, E., Motz, E., Lizzio, S., Gonano, F. & Bartoli, E. (1994) Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thrombosis and Haemostasis, 71, 593-595.
12. Chantarangkul, V., Tripodi, A. & Mannucci, P.M. (1994) Results of a collaborative study for fibrinogen measurement: evidence that the use of a common calibrator improves interlaboratory agreement. Blood Coagulation and Fibrinolysis, 5, 761-766.
13. Chitolie, A., Mackie, I.J., Grant, D., Hamilton, J.L. & Machin, S.M. (1994) Inaccuracy of the 'derived' fibrinogen measurement. Blood Coagulation and Fibrinolysis, 5, 955-957.
14. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Marcucci, G., Sorlie, P. & Wu, K.K. (1994) Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. Thrombosis and Haemostasis, 72, 551-556.
15. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P., Marcucci, G. & Wu, K.K. (1993a) Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. Thrombosis and Haemostasis, 70, 380-385.
16. Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P. & Wu, K.K. (1993b) Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the ARIC Study. Thrombosis and Haemostasis, 70, 762-767.
17. Cortellaro, M. (1991) Antithrombin III and arterial disease. Lancet, 338, 1525-1526.
18. Ernst, E. & Resch, K.L. (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Annals of Internal Medicine, 118, 956-963.
19. Folsom, A.R., Conlan, M.G., Davis, C.E. & Wu, K.K. (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Annals of Epidemiology, 2, 481-494.
20. Gaffney, P.J. & Wong, M.T. (1992) Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis, 68, 428-432.
21. Giansante, C., Fiotti, N., Cattin, L., Da Col, P.G. & Calabrese, S. (1994) Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors. Thrombosis and Haemostasis, 71, 581-586.
22. Giddings, J.C. & Peake, I.R. (1985) The investigation of factor VIII deficiency. Blood Coagulation and Haemostasis: a Practical Guide (ed. by J. M. Thomson), pp. 135-207. Churchill Livingstone, Edinburgh.
23. Hampton, K.K., Preston, F.E., Lowe, G.D.O., Walker, I.D. & Sampson, B. (1993) Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate. British Journal of Haematology, 84, 279-284.
24. Heinrich, J., Balleisen, L., Schulte, H., Assmann, G. & van de Loo, J. (1994) Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men. Arteriosclerosis and Thrombosis, 14, 54-59.
25. Ibbotson, S.H., Davies, J.A. & Grant, P.J. (1992) The influence of infusion of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on thrombin generation in vitro. Thrombosis and Haemostasis, 68, 37-39.
26. Iso, H., Folsom, A.R., Wu, K.K., Finch, A., Munger, R.G. & Sato, S. (1989) Hemostatic variables in Japanese and Caucasian men: plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. American Journal of Epidemiology, 130, 925-934.
27. Lee, A.J., Lowe, G.D.O., Smith, W.C.S. & Tunstall-Pedoe, H.D. (1993) Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy. British Journal of Haematology, 83, 616-621.
28. Lowe, G.D.O., Fowkes, F.G.R., Koenig, W. & Mannucci, P.M. (eds) (1995) Fibrinogen and cardiovascular disease. European Heart Journal. Supplement A.
29. Lowe, G.D.O., Wood, D., Douglas, J.T., Riemersma, R.A., Macintyre, C.C.A., Takase, I., Tuddenham, E.G.D., Forbes, C.D. & Oliver, M.F. (1991) Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thrombosis and Haemostasis, 65, 339-343.
30. Mannucci, P.M., Bauer, K.A., Gringeri, A., Barzegar, S., Santagostino, E., Tradati, F.C. & Rosenberg, R.D. (1990) Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. Blood, 76, 2540-2545.
31. Mannucci, P.M., Tripodi, A., Bottasso, B., Baudo, F., Finazzi, G., de Stefano, V., Palareti, G., Manotti, C., Mazzucconi, M.G. & Castaman, G. (1992) Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thrombosis and Haemostasis, 67, 200-202.
32. Meade, T.W. (1994) Haemostatic function, arterial disease and the prevention of arterial thrombosis. Bailliere's Clinical Haematology, 7, 733-755.
33. Meade, T.W., Brozovic, M., Chakrabarti, R., Howarth, D.J., North, W.R.S. & Stirling, Y. (1976) An epidemiological study of the haemostatic and other effects of oral contraceptives. British Journal of Haematology, 34, 353-364.
34. Meade, T.W., Cooper, J., Miller, G.J., Howarth, D. & Stirling, Y. (1991) Antithrombin III and arterial disease. Lancet, 337, 850-851.
35. Meade, T.W., Cooper, J.A., Stirling, Y., Howarth, D.J., Ruddock, V. & Miller, G.J. (1994) Factor VIII, ABO blood group and the incidence of ischaemic heart disease. British Journal of Haematology, 88, 601-607.
36. Meade, T.W., Dyer, S., Howarth, D.J., Imeson, J.D. & Stirling, Y. (1990) Antithrombin III and procoagulant activity: sex differences and effects of the menopause. British Journal of Haematology, 74, 77-81.
37. Meade, T.W., Haines, A.P., Imeson, J.D., Stirling, Y. & Thompson, S.G. (1983) Menopausal status and haemostatic variables. Lancet, i, 22-24.
38. Meade, T.W., Mellows, S., Brozovic, M., Miller, G.J., Chakrabarti, R.R., North, W.R.S., Haines, A.R., Stirling, Y., Imeson, J.D. & Thompson, S.G. (1986a) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, ii, 533-537.
39. Meade, T.W., North, W.R.S., Chakrabarti, R., Haines, A.P. & Stirling, Y. (1977) Population-based distributions of haemostatic variables. British Medical Bulletin, 33, 283-288.
40. Meade, T.W., North, W.R.S., Chakrabarti, R.R., Stirling, Y., Haines, A.P. & Thompson, S.G. (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet, i, 1050-1054.
41. Meade, T.W., Stirling, Y., Thompson, S.G., Vickers, M.W., Woolf, L., Ajdukiewics, A.B., Stewart, G., Davidson, J.F., Walker, I.D., Douglas, A.S., Richardson, I.M., Weir, R.D., Aromara, A., Impivaara, O., Maatela, J. & Hladovec, J. (1986b) An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. International Journal of Epidemiology, 15, 331-336.
42. Miller, G.J., Wilkes, H.C., Meade, T.W., Bauer, K.A., Barzegar, S. & Rosenberg, R.D. (1991) Haemostatic changes that constitute the hypercoagulable state. Lancet, 338, 1079.
43. Nabulsi, A.A., Folsom, A.R., White, A., Patsch, W., Heiss, G., Wu, K.K., for the ARIC Investigators (1993) Associations of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine, 328, 1069-1075.
44. Ogston, D. (1983) The Physiology of Hemostasis. Croom Helm, Beckenham.
45. Peake, I.R., Lillicrap, D.P.O., Boulyjenkov, V., Briet, E., Chan, V., Ginter, E.K., Kraus, E., Ljung, R., Mannucci, P.M., Nicolaides, K. & Tuddenham, E.G.D. (1993) Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coagulation and Fibrinolysis, 4, 313-344.
46. Pelzer, H., Schwarz, A. & Stuber, W. (1991) Determination of human prothrombin activation fragment F1, 2 in plasma with an antibody against a synthetic peptide. Thrombosis and Haemostasis, 65, 153-159.
47. Phillippou, H., Adami, A., Lane, D.A., McGregor, I.R., Tuddenham, E.G.D., Lowe, G.D.O., Rumley, A. & Ludlam, C.A. (1996) High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC. Thrombosis and Haemostasis, 76, 23-28.
48. Rossi, E., Mondonico, P., Lombardi, A. & Preda, L. (1988) Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thrombosis Research, 52, 453-458.
49. Silviera, A., Karpe, F., Blomback, M., Steiner, G., Walldius, G. & Hamsten, A. (1994) Activation of coagulation factor VII during alimentary lipemia. Arteriosclerosis and Thrombosis, 14, 60-69.
50. Simpson, N.E. & Biggs, R. (1962) The inheritance of Christmas factor. British Journal of Haematology, 8, 191-203.
51. Skouby, S.O. & Jespersen, J. (eds) (1990) First European Conference on Sex Steroids and Metabolism. American Journal of Obstetrics and Gynecology, 163, Supplement, 343-348.
52. Stewart, M.E., Douglas, J.T., Lowe, G.D.O., Prentice, C.R.M. & Forbes, C.D. (1983) Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia. Lancet, ii, 479-482.
53. Tait, R.C., Walker, I.D., Islam, S.I.A.M., McCall, F., Conkie, J.A., Mitchell, R. & Davidson, J.F. (1993a) Influence of demographic factors on antithrombin III activity in a healthy population. British Journal of Haematology, 84, 476-480.
54. Tait, R.C., Walker, I.D., Islam, S.I.A.M., McCall, F., Conkie, J.A., Wight, M., Mitchell, R. & Davidson, J.F. (1993b) Protein C activity in healthy volunteers: influence of age, sex, smoking and oral contraceptives. Thrombosis and Haemostasis, 70, 281-284.
55. Tripodi, A., Chantarangkul, V., Bottasso, B. & Mannucci, P.M. (1994) Poor comparability of prothrombin fragment 1 + 2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards. Thrombosis and Haemostasis, 71, 605-608.
56. Woodward, M., Lowe, G.D.O., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D.A. & Morrison, C.E. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97, 785-797.
57. World Health Organization Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of Clinical Epidemiology, 41, 105-113.
58. World Health Organization Principal Investigators (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation, 90, 583-612.